 鲜花( 85)  鸡蛋( 2)
|
楼主 |
发表于 2015-2-28 21:48
|
显示全部楼层
Stock soars after Cold-fX wins crucial approval
/ _. \$ b+ W8 M! Y% D: @2 f7 B
; Z, [8 ]8 k+ C3 b" j( R: E4 AEDMONTON - CV Technologies Inc. shares rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.$ g* i0 ]' L0 w, T/ h4 e9 G0 M
% `( F r7 V. H: L; K
BY THE EDMONTON JOURNAL FEBRUARY 16, 2007
' z2 ~( j7 b& }7 k0 t) }: {
2 U7 k- A; X% `1 L q; W* x
" C2 H- `% T3 \EDMONTON - CV Technologies Inc. SHARES rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.
5 N# E1 \: {# K, w: U1 q4 Z
$ T- v8 A; A& b. N- q: n/ P' iThe agency said CV Technologies can continue to market Cold-fX as helping "to reduce the frequency, severity and duration of cold and flu symptoms by boosting the IMMUNE SYSTEM."8 C; H6 m( G' v! p. J0 k
, z. q7 ?! l' D0 s1 ?The APPROVAL follows a review of seven clinical trials and more than 10 years of research about the product.
5 f D0 x6 h- \; O" t4 m( w4 {9 {$ l6 g$ h
It should create even more confidence among consumers and medical professionals that the product works, CEO Jacqueline Shan said Thursday.
8 Z" } o2 K0 R. }8 F
4 H7 @' c7 A& D g1 K6 ?It certainly instilled confidence in the market, as shares closed at $2.90 on THE TORONTO STOCK EXCHANGE, up $1.08 on a volume of 4.6 million.- i# L: w3 i6 I. m3 `! X* c, K
2 z2 }: |+ e3 w& _9 G8 S"As a scientist, it's one of the highlights of my CAREER," Shan said.
: ], l7 j/ P8 G L4 p8 J
5 n0 k- S4 `6 B8 s6 r# ^2 T"This approval is a breakthrough in realizing our vision of being a global leader in developing products for disease prevention."
" c; J' n6 }1 `
3 S$ w" S: M, @7 ? BIt's Cold-fX's strongest medical recognition to date, said Shan. It means the company can advertise the HEALTH BENEFITS more effectively to consumers and health professionals, she said.
) K9 n# ]) V! U
B2 V, F2 i- Y+ u, I) rGinseng-based Cold-fX is already the top-selling cold and flu treatment in Canada, but Shan said there is plenty of room for more growth.
- B; J9 J& N% f# y
/ ]2 O6 G) \! O cThe approval will also help raise the product's PROFILE in the lucrative U.S. market, which Cold-fX entered in October. The move came with a new marketing push, using former Oilers superstar Mark Messier as its spokesman./ ?: F9 g( J7 t& ^5 N7 z
* D+ U. {; a* N# T0 ~
; L" i/ L- N, h# E
http://www.canada.com/story.html ... 9-be80-f40f1426f662 |
|
狗仔卡
发表于 2015-2-28 18:25
提升卡
置顶卡
沉默卡
喧嚣卡
变色卡
显身卡
发表于 2015-2-28 19:45
